More than a decade after severing ties to RNAi pioneer Alnylam, Novartis has returned to the deal table for an ambitious early-stage collaboration to restore liver function in patients with end-stage…
Canadian services firm Altasciences has acquired Missouri preclinical CRO Sinclair Research, citing a desire to expand in the U.S.
In a keynote address at the annual CES conference, Abbott CEO Robert Ford introduced Lingo, a new line of consumer biowearable sensors.
Eikon Therapeutics, the drug discovery startup with a former Merck & Co. research chief at the helm, has appointed a pantheon of biotech veterans on its quest to take its live-cell imaging platform to…
Eli Lilly has picked up exclusive right to Entos’ Fusogenix nucleic acid delivery technology, which it will use to research, develop and potentially sell nucleic acid-based therapeutics against…
NovAliX has acquired a former Sanofi site in Strasbourg, France, where the French CRO plans to build a new research campus.
Virtue may be its own reward, but for Virtue Diagnostics, at least, a fresh infusion of venture capital is a close second.
A University of Pennsylvania team of renowned scientists in mRNA and T-cell immunotherapy have harnessed the power of both technologies in a promising experimental therapy to repair heart damage.
Verily and Sosei Heptares are hitching their wagons to the rising star of G-protein-coupled receptors to develop new drugs for immune-based disorders.
